课题基金 / 基金详情

RISK FACTORS FOR PROGRESSION OF CHRONIC RENAL DISEASE

RISK FACTORS FOR PROGRESSION OF CHRONIC RENAL DISEASE
慢性肾病进展的危险因素
批准号:
2444173
负责人:
MACKENZIE WALSER
金额:
$14.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-20 至 1999-06-30

项目摘要

项目成果

MACKENZIE WALSER的其他基金

相似基金

相关文献

中文摘要
翻译
描述:
英文摘要
DESCRIPTION: Rates of progression vary widely among patients with chronic renal failure. In most series, at least 15% of patients do not progress at all for years; at the other extreme, some patients lose glomerular filtration rates (GFR's) as rapidly as three ml/min/mo. Previous studies, entitled "Modification of Diet in Renal Disease (MDRD)," have randomized 925 patients to various diets and blood pressure targets and followed them for an average of two years with sequential GFR's. This data set is unique in having documented greater than 6,000 GFR's. Multivariate analysis of the determinants of rates of progression among these patients has so far been able to account for no more than a small proportion of the variability in observed rates of progression. In another series of 104 patients, the applicant has identified four analyses whose levels correlate strongly with rates of progression: serum free tryptophan, serum dehydroepiandrosterone sulfate, urinary nitrate, and urinary 17-hydroxycorticosteroids. They propose to measure these analyses plus serum transforming growth factors in frozen samples from the feasibility and full-scale MDRD studies, and to determine by regression techniques how much of the observed variability in progression rates can be accounted for by these analyses. The extent to which this predictive power is independent of presently identified predictors of renal disease progression will be studied. They will also determine whether these analyses were altered by the dietary and blood pressure interventions of the MDRD studies, and the extent to which these analyses explain the observed association of achieved blood pressure and achieved protein intake with progression. The applicant indicates that the results will have important implications for the understanding the pathogenesis of progression and may point to new therapeutic approaches to slowing progression.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Effects of a supplemented very low protein diet in predialysis patients on the serum albumin level, proteinuria, and subsequent survival on dialysis.
透析前患者补充极低蛋白饮食对血清白蛋白水平、蛋白尿和随后透析生存的影响。
DOI: 10.1159/000057352
发表时间: 1998
期刊: Mineral and electrolyte metabolism.
影响因子: --
作者: [Walser,M]
通讯作者: Walser,M
Nutritional Therapy of the Nephrotic Syndrome
  • 批准号:
    7044578
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2003
  • 负责人:
    MACKENZIE WALSER
  • 依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
  • 批准号:
    6218187
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    1998
  • 负责人:
    MACKENZIE WALSER
  • 依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
  • 批准号:
    6114276
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    MACKENZIE WALSER
  • 依托单位:
PHASE II TRIAL OF DHEA IN CHRONIC RENAL FAILURE
  • 批准号:
    6114381
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    MACKENZIE WALSER
  • 依托单位:
海外基金